Objective: To evaluate the association between maternal interleukin (IL)-6 G(À174)C polymorphism and cystic periventricular leukomalacia (cPVL) of the preterm newborn.
Introduction
Chorioamnionitis is a well-known risk factor for preterm delivery 1 and also has been associated with brain damage in preterm infants. 2 High levels of proinflammatory cytokine levels have been found in umbilical blood samples in the presence of histologic chorioamnionitis. 3 Experimental models of intrauterine infection have been associated with focal white matter cysts that mimic cystic periventricular leukomalacia (cPVL) in the preterm infant. 4, 5 Clinical evidence for this pathogenesis is supported by the finding that chorioamnionitis or funisitis is associated with development of cPVL. [6] [7] [8] [9] Interleukin-6 (IL-6) is essential for normal brain function under normal conditions as well as during injury, 10 but despite its neuroprotective effects increased IL-6 expression may be harmful during the early stage of injury. 11 The magnitude of the inflammatory response to infectious stimuli is partly regulated by genetic factors. A functional G-C polymorphism at position À174 relative to the transcription start point of IL-6 is associated with lower expression using a gene reporter assay. 12 In vitro, IL-6 production in lipopolysaccharide-stimulated mononuclear cells was higher in the CC genotype in newborn infants. 13 In contrast, inconsistent results between the different IL-6 genotypes and IL-6 plasma levels were observed in adults. 13 Recently, it is found that the IL-6(À174) GG and (À572) GC genotypes were associated with a higher incidence of histologic chorioamnionitis, and the IL-6(À174) CC genotype was associated with septicemia in preterm infants. 14 We recently reported the results of the IL-6 G(À174)C polymorphism in 52 children with cPVL compared with 46 preterm and 395 term controls. 15 IL-6 G(À174)C polymorphisms did not differ between groups, but an association between mental retardation and IL-6 C/C (78%) and G/C (43%) compared with G/G (25%) genotype was found in cases (P ¼ 0.003 and 0.043, relative risks 3.11 (95% confidence interval (CI) 1.54 to 6.29) and 1.79 (95% CI 1.10 to 2.92), respectively).
The aim of this study was to evaluate the role of maternal IL-6 G(-174)C polymorphism in the development of cPVL of the preterm infant.
Methods
The study group (cases) included Caucasian mothers of children with diagnosis of cPVL of a single-center cohort admitted to hospital at the Division of Neonatology, Department of Pediatrics, Medical University of Graz between 1988 and 2005. The database had 132 cases. This is a planned analysis of the maternal cohort, the pediatric cohort analysis has been reported previously. 15 Study patients were contacted by phone or letters and included after informed consent was taken. The control group (controls) included a historical group of Caucasian mothers with preterm infants who have neither developed cPVL nor early onset sepsis. The study results have been published elsewhere. 16 Subgroup analysis was carried out in cases with either history of preterm premature rupture of the membranes (PPROM) or clinical chorioamnionitis (CCA). For further comparisons, data from umbilical cord blood samples from a consecutive birth cohort of healthy newborns were collected between February 2002 and May 2002 at the Department of Gynecology and Obstetrics, Graz, and published data from Caucasian populations 17-21 were used. The study was approved by the local ethics committee (number 16-049 ex 04/05).
Blood sampling (5 ml EDTA blood) was carried out either at the outpatient clinic of Neonatal Follow-up (most cases) or ambulatory at visits to practitioners. Blood was stored at À20 1C and blood sampls were sent to the Department of Medical and Chemical Laboratory Diagnostics at the Medical University of Vienna. All samples were coded and genetic analysis was performed in a masked manner.
Preterm premature rupture of the membrane was defined as rupture of the amniotic membranes before the onset of labor in case of preterm birth. CCA was defined as maternal fever higher than 38 1C together with at least one of the following symptoms: maternal or fetal tachycardia, uterine tenderness, foul-smelling amniotic fluid or maternal leukocytosis. Cystic PVL was diagnosed by bedside serial cranial ultrasound scans revealing periventricular echodensities loco typico within the first days of life that evolved to cysts and were confirmed in both the coronal and sagittal planes as described elsewhere. 9 For determination of the IL-6 promoter polymorphism, a mutagenic separated polymerase chain reaction assay was used essentially as described previously. 22 Briefly, in this mutagenic separated polymerase chain reaction, one common and two allelespecific primers that differ in length by 9 bp are used in one single tube. Base mismatches at defined positions in the allele-specific primers minimize cross-reactions of the PCR products generated from the two alleles during PCR amplification. Mutagenically separated PCRs were performed in a PerkinElmer 9700 Cycler (Applied Biosystems) using 50 ml reaction volumes containing 5 ml 10 Â buffer, approximately 50 ng DNA, 1.5 mM MgCl 2 , 200 mM each dNTP, 1.25 U AmpliTaq Gold and the following primers: 13 pmol IL-6(À174G) forward primer 5-TCCCCCTAGTTGTGTCTCGCG-3; 5 pmol IL-6(À174C) forward primer 5-CTGCACTTTATCCCCTAGTTGTGTCATGCC-3 and 13 pmol IL-6 common reverse primer 5-TGAGGGTGGGGCCAGAGC-3 (all from TIB Molbiol, Berlin, Germany). A 10-min denaturation at 95 1C was followed by 37 cycles at 95 1C for 30 s, 58 1C for 45 s and 72 1C for 60 s, and a final extension step of 7 min at 72 1C. The PCR products were analyzed using gel electrophoresis on 6% precast polyacrylamide Novex gels (Invitrogen, Carlsbad, CA, USA) at 160 V for 50 min and stained for 20 min with SYBR Green (Roche, Vienna, Austria) (1:10 000 dilution). The PCR product generated from the G-allele has a length of 95 bp; the C-allele gives a 104 bp product. Both alleles can easily be distinguished by length on polyacrylamide gels. In every sample, one or two different products are generated depending on the genotype. A reagent control without DNA served as a negative control.
Statistical analysis
The genotype frequency and allele frequency were calculated by direct counting and then dividing by the number of subjects or the number of chromosomes to produce genotype and allele frequencies, respectively. The data were tested for the fit to Hardy-Weinberg equilibrium by calculating expected frequencies of genotypes and comparing them with the observed values. Possible deviations from the Hardy-Weinberg equilibrium were calculated with a standard Pearson's w 2 -test. The comparisons with the control group were performed with w 2 -test or Fisher's exact test, depending on expected values, using NCSS (NCSS, Kaysville, UT, USA). For all statistical tests, we considered 0.05 as the level of significance. Odds ratio and 95% CIs were calculated using the software package CIA-Confidence Interval Analysis (version 2.0.0; Statistics with Confidence, London, UK, BMJ publishing group 2000). Multivariate analysis was performed with a logistic IL-6 polymorphism and periventricular leucomalacia B Resch et al regression model using SAS (SAS Institute Inc., Cary, NC, USA), SPSS (SPSS Inc., Chicago, IL, USA) and StatXact4 and LogXact (both from Cytel, Cambridge, MA, USA). The sample size was calculated based on a statistical power of 80% with a level of significance of 5% (0.05) using a sample size calculator model for multiple regression. The minimum required sample size was 31 by using two predictors and an anticipated effect size (f 2 ) of 0.35.
Results
A total of 44 cases were compared with 41 controls and additionally compared with results from a cohort of 395 term infants and with published data from 1104 Caucasian adults. [18] [19] [20] [21] [22] Contact with parents was positive in 128 of 132 cases (97%), 4 mother-child pairs were lost to follow-up. Failure of enrollment was due to refusal to participate in the study in all remaining cases.
Selected perinatal characteristics of cases and controls are shown in Table 1 . Baseline characteristics did not differ between groups. Differences were observed regarding multiple gestation, PPROM and CCA. Developmental follow was performed at a median age of 28 months. Cerebral palsy and mental retardation rates were 80 and 45%, respectively, in the cases compared with 2 and 2%, respectively, in the controls.
Results of the IL-6 G(À174)C polymorphisms did not differ between cases (GG 29.5%, GC 54.5% and CC 15.9%) and controls (GG 34.2%, GC 51.2% and CC 14.6%). No differences were found between 31 cases with history of PPROM (GG 25.8%, GC 54.8% and CC 19.4%) and controls. A significantly higher frequency of the CC genotype was found in 23 cases with a history of CCA (34.8%) compared with controls by either univariate (P ¼ 0.032; odds ratio 3.11, 95% CI 1.11 to 8.68) or multivariate analysis (P ¼ 0.049, odds ratio 2.54, 95% CI 1.01 to 6.45). These data were confirmed by a comparison of the CC genotype frequency to 395 term controls (CC 14.7%, P ¼ 0.005) and to the mean CC genotype frequency of 1104 Caucasian adults (CC 15.6%, P<0.0001).
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Discussion
In our candidate gene-association study we found no differences between mothers of children with and without cPVL regarding frequencies of the IL-6 G(À174)C polymorphisms, but an association of the IL-6 (À174) CC genotype with CCA and preterm birth with a threefold increased risk for the development of cPVL in the preterm offspring. The observed frequencies of the polymorphisms in our cases and controls as well as in our term infants group were in accordance with published data for Caucasian populations. [18] [19] [20] [21] [22] Interestingly, African Americans and Asians are known to have significantly lower frequencies of the C/C genotype. 23 Our study has certain limitations. There might be a selection bias as more than two thirds of the mothers refused to participate in the study. Owing to the design of the study an assay of IL-6 levels was impossible. But results from measurements of cytokine concentrations, however, vary depending on the timing in relation to delivery, presence of infection, fetal stress and a multitude of other factors, making their interpretation difficult. 24 Differences of allele frequencies between cases, controls, term infants and reported frequencies of Caucasian adults using the Hardy-Weinberg equilibrium were not significant, allowing us to additionally compare the observed frequencies to these data. We found a significant association between CCA and CC genotypes in a relatively small subgroup of mothers, these results might have been even more pronounced in a larger sample. At least significant differences between cases and controls regarding percentage of PPROM and CCA might primarely direct the influence of the C/C genotype to maternal inflammation and secondarily to inflammation of the preterm brain.
Owing to the significant association of PPROM and CCA with cPVL in the preterm offspring, [6] [7] [8] [9] obviously through an exaggerated fetal inflammatory response syndrome, it is difficult to speculate about the role of the IL-6 CC genotype. Thus, two questions arise: first, is this an association with an increased risk for CCA and/or a more severe infection in the mother, or second, is it an association with cPVL of the preterm infant through the fetal inflammatory response? Both the maternal CG and GG genotypes have recently been associated with histological or CCA and the infants CC genotype with neonatal infection. 14, 24 Results of our previously published data on the IL-6 G(À174)C polymorphism in children with and without cPVL revealed a significant association of the CC and GC genotypes with mental retardation in cPVL, suggesting that the severity of perinatal brain damage might be modified by these genotypes. 15 Recently, two studies have reported on an association of postnatal sepsis and/or necrotizing enterocolitis with white matter injury of the premature infant. 25, 26 Whether the maternal C/C polymorphism was associated with CCA and early onset sepsis in our study cohort leading to cPVL through an exaggerated fetal inflammatory response syndrome remains highly speculative. The reported association of the preterm infants' IL-6 (À174) G polymorphism with histological chorioamnionitis does not support this theory. 24 In our opinion the association of the maternal CC genotype with chorioamnionitis and cPVL might be directed more toward the fetal inflammatory response.
In fact, the published data including our findings on genetics and perinatal brain injury suggest a role for cytokine genes as risk modifiers for cPVL. Further studies are needed to explore the relationship among PPROM and/or CCA, preterm delivery, IL-6 genotype, fetal inflammatory response and brain injury of the preterm infant.
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